PolyPeptide Group AG announced that for 2024, the company expands a mid- to high single-digit revenue growth at constant currency rates. The company do expect to operate a net loss.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
29.55 CHF | +1.90% | 0.00% | +68.66% |
Mar. 12 | PolyPeptide Group AG Provides Earnings Guidance for 2024 | CI |
Mar. 12 | Transcript : PolyPeptide Group AG, 2023 Earnings Call, Mar 12, 2024 |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+68.66% | 1.08B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- PPGN Stock
- News PolyPeptide Group AG
- PolyPeptide Group AG Provides Earnings Guidance for 2024